UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.85 +0.83 (+1.06%) GOLD FUTURES
2,393.30 +33.40 (+1.42%) DOW
39,908.00 +349.89 (+0.88%) Bitcoin GBP
52,059.27 +3,510.17 (+7.23%)
Acura Pharmaceuticals, Inc. (ACUR)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 03:39PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 270.61k |
| Enterprise value | 405.61k |
| Trailing P/E | 7.00 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.15 |
| Price/book (mrq) | 1.52 |
| Enterprise value/revenue | 1.55 |
| Enterprise value/EBITDA | -4.61 |
Trading information
Stock price history
| Beta (5Y monthly) | 48.20 |
| 52-week change 3 | -91.80% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 0.0500 |
| 52-week low 3 | 0.0001 |
| 50-day moving average 3 | 0.0053 |
| 200-day moving average 3 | 0.0018 |
Share statistics
| Avg vol (3-month) 3 | 1.05k |
| Avg vol (10-day) 3 | 104 |
| Shares outstanding 5 | 66M |
| Implied shares outstanding 6 | 66M |
| Float 8 | 9.94M |
| % held by insiders 1 | 84.73% |
| % held by institutions 1 | 2.96% |
| Shares short (31 Jan 2017) 4 | 89.85k |
| Short ratio (31 Jan 2017) 4 | 0.73 |
| Short % of float (31 Jan 2017) 4 | 1.20% |
| Short % of shares outstanding (31 Jan 2017) 4 | 0.76% |
| Shares short (prior month 30 Dec 2016) 4 | 76k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 28 Aug 2015 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2021 |
| Most-recent quarter (mrq) | 31 Dec 2021 |
Profitability
| Profit margin | -56.24% |
| Operating margin (ttm) | -658.33% |
Management effectiveness
| Return on assets (ttm) | -58.46% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 1.56M |
| Revenue per share (ttm) | 0.03 |
| Quarterly revenue growth (yoy) | -95.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -1.14M |
| Net income avi to common (ttm) | -879k |
| Diluted EPS (ttm) | -0.0200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | 150k |
| Total debt/equity (mrq) | 84.27% |
| Current ratio (mrq) | 0.72 |
| Book value per share (mrq) | 0.00 |
Cash flow statement
| Operating cash flow (ttm) | -742k |
| Levered free cash flow (ttm) | -1.1M |
© 2024 Yahoo. All rights reserved.